Cargando…

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer

OBJECTIVES: The purpose of this study was to evaluate whether immune checkpoint inhibitors (ICIs) are associated with an increased risk of major adverse cardiovascular events (MACE) compared with non-ICI therapies in patients with lung cancer. BACKGROUND: ICIs activate the host immune system to targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitturi, Kalyan R., Xu, Jiaqiong, Araujo-Gutierrez, Raquel, Bhimaraj, Arvind, Guha, Ashrith, Hussain, Imad, Kassi, Mahwash, Bernicker, Eric H., Trachtenberg, Barry H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352266/ https://www.ncbi.nlm.nih.gov/pubmed/34396181 http://dx.doi.org/10.1016/j.jaccao.2019.11.013

Ejemplares similares

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
por: Araujo-Gutierrez, Raquel, et al.
Publicado: (2021)

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
por: Araujo-Gutierrez, Raquel, et al.
Publicado: (2018)

Insights on Infiltrative and Restrictive Cardiomyopathies
por: Trachtenberg, Barry, et al.
Publicado: (2022)

Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
por: Anand, Kartik, et al.
Publicado: (2019)

Combined Heart-Kidney Transplantation: Indications, Outcomes, and Controversies
por: Ahsan, Syed Adeel, et al.
Publicado: (2022)

Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report
por: Chitturi, Kalyan R, et al.
Publicado: (2020)

Implication of Ventricular Assist Devices in Extracorporeal Membranous Oxygenation Patients Listed for Heart Transplantation
por: Guha, Ashrith, et al.
Publicado: (2019)

Elevated Pressures on Aortic Valve Leaflets correlate with Orientation of LVAD Outflow Graft
por: Karmonik, Christof, et al.
Publicado: (2015)

2693. Epidemiology of Infections with Multidrug-Resistant Organisms in Patients with Left Ventricular Assist Devices (LVADs)
por: Axell-House, Dierdre B, et al.
Publicado: (2023)

Inflammatory Cardiomyopathies: A Need to Identify Indolent Inflammation
por: Ali, Hyeon-Ju Ryoo, et al.
Publicado: (2022)

Refractory Impella Suction Alarms in the Setting of Extracorporeal Membrane Oxygenation
por: Aoun, Joe, et al.
Publicado: (2021)

Characteristics and Outcomes of Left Ventricular-Assist Device-Associated Cerebrovascular Events in Setting of Infectious Intracranial Aneurysms
por: Garg, Tanu, et al.
Publicado: (2021)

Innovative Modeling Techniques and 3D Printing in Patients with Left Ventricular Assist Devices: A Bridge from Bench to Clinical Practice
por: Thaker, Rishi, et al.
Publicado: (2019)

The Dawn of the Invasive Heart Failure Specialist
por: Kassi, Mahwash
Publicado: (2021)

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
por: Kassi, Eva, et al.
Publicado: (2019)

Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
por: Jain, P., et al.
Publicado: (2021)

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
por: Kasparian, Saro, et al.
Publicado: (2020)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
por: Luo, Lingli, et al.
Publicado: (2023)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
por: Lal, Jessica Castrillon, et al.
Publicado: (2021)

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021)

Drs. Sandeep Sahay and Ashrith Guha Lead Issue on Pulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Hemodynamic Assessment of Dual Obstructive Left Ventricular Assist Device Lesions
por: Kassi, Mahwash, et al.
Publicado: (2021)

Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
por: Guha, Avirup, et al.
Publicado: (2022)

Management of adverse events related to checkpoint inhibition therapy
por: Rudzki, Jakob Daniel
Publicado: (2018)

Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy
por: Vani, Vanina, et al.
Publicado: (2020)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors
por: Gujral, Dorothy M., et al.
Publicado: (2020)

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
por: Naidoo, Jarushka, et al.
Publicado: (2017)

Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan
por: Kassi, Masoom, et al.
Publicado: (2008)

Identifying people at high risk for developing sleep apnea syndrome (SAS): a cross-sectional study in a Pakistani population
por: Taj, Fawad, et al.
Publicado: (2008)

Neuroendocrine Tumor Involving the Epicardium
por: Soyano, Aixa E., et al.
Publicado: (2017)

Acute Circulatory Collapse and Advanced Therapies in Patients with COVID-19 Infection
por: Thaker, Rishi, et al.
Publicado: (2021)

Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy
por: Ashrith, Guha, et al.
Publicado: (2014)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Wang, Zheng-Hang, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
por: Herrmann, Sandra M., et al.
Publicado: (2020)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
por: Si, Xiaoyan, et al.
Publicado: (2019)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
por: Rajha, Eva, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5q4ossoflc7t6bk2imkr741rsi